BCL2L1 and pulmonary arterial hypertension: BMPRII deficiency impairs apoptosis via the BMPRII-ALK1-BclX (B-cell lymphoma X)-mediated pathway and the Bcl-xL isoform could be a potential biomarker for PAH [25].